Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.
2.
3.

The effects of behavioral parent training on families with young hyperactive children.

Erhardt D, Baker BL.

J Behav Ther Exp Psychiatry. 1990 Jun;21(2):121-32.

PMID:
2273073
4.

Parent-assisted transfer of children's social skills training: effects on children with and without attention-deficit hyperactivity disorder.

Frankel F, Myatt R, Cantwell DP, Feinberg DT.

J Am Acad Child Adolesc Psychiatry. 1997 Aug;36(8):1056-64.

PMID:
9256585
6.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
7.
8.

Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning.

DuPaul GJ, McGoey KE, Eckert TL, VanBrakle J.

J Am Acad Child Adolesc Psychiatry. 2001 May;40(5):508-15.

PMID:
11349694
12.

Combined type versus ADHD predominantly hyperactive-impulsive type: is there a difference in functional impairment?

Riley C, DuPaul GJ, Pipan M, Kern L, Van Brakle J, Blum NJ.

J Dev Behav Pediatr. 2008 Aug;29(4):270-5. doi: 10.1097/DBP.0b013e31816b6afe.

PMID:
18454040
13.

Effectiveness of behavioral parent training for children with ADHD in routine clinical practice: a randomized controlled study.

van den Hoofdakker BJ, van der Veen-Mulders L, Sytema S, Emmelkamp PM, Minderaa RB, Nauta MH.

J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1263-71.

PMID:
17885567
14.

Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics.

Johnston C, Hommersen P, Seipp C.

Behav Ther. 2008 Mar;39(1):22-32. doi: 10.1016/j.beth.2007.04.002. Epub 2007 Oct 18.

PMID:
18328867
15.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
16.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group..

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.

PMID:
19716683
17.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
18.

Creating opportunities for parent empowerment: program effects on the mental health/coping outcomes of critically ill young children and their mothers.

Melnyk BM, Alpert-Gillis L, Feinstein NF, Crean HF, Johnson J, Fairbanks E, Small L, Rubenstein J, Slota M, Corbo-Richert B.

Pediatrics. 2004 Jun;113(6):e597-607.

PMID:
15173543
19.

Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.

Matza LS, Secnik K, Mannix S, Sallee FR.

Pharmacoeconomics. 2005;23(8):777-90.

PMID:
16097840
20.

Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study.

Bakken RJ, Paczkowski M, Kramer HP, Axelson AA, Williams DW, Malcolm SK, Sumner CR, Kelsey DK.

Curr Med Res Opin. 2008 Feb;24(2):449-60. doi: 10.1185/030079908X253627 .

PMID:
18179733

Supplemental Content

Support Center